Oxaliplatin ± Nivolumab in Combination With Trifluridine/Tipiracil or 5-fluorouracile in Frail Patients With Advanced, Recurrent or Metastatic Gastric, Oesophageal or Gastroesophageal Junction Cancer

Recruiting

Phase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.

Trial locations(29 sites)

France

Clinique de l'Europe, Amiens

Hopital Privé Arras Les Bonnettes, Arras

Institut Sainte Catherine, Avignon

Centre Hospitalier de Beauvais, Beauvais

CHU Besançon - Hôpital Jean Minjoz, Besançon